Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers (Q39550412)

13 September 2017

title

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers (English)

1 reference

13 September 2017

8

1 reference

13 September 2017

Y Wang

1

1 reference

13 September 2017

T Romigh

2

1 reference

13 September 2017

X He

3

1 reference

13 September 2017

M-H Tan

4

1 reference

13 September 2017

M S Orloff

5

1 reference

13 September 2017

R H Silverman

6

1 reference

13 September 2017

W D Heston

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

2 May 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

30

1 reference

13 September 2017

issue

42

1 reference

13 September 2017

page(s)

4327-4338

1 reference

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Androgens induce divergent proliferative responses in human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

The amino terminus of the human AR is target for corepressor action and antihormone agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

PTEN: one gene, many syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

R: A Language for Data Analysis and Graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

AKT regulates androgen receptor-dependent growth and PSA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Regulation of PTEN transcription by p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Regulation of the PTEN promoter by statins and SREBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Cancer phenomics: RET and PTEN as illustrative models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

PTEN Autoregulates Its Expression by Stabilization of p53 in a Phosphatase-Independent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.144

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.144

1 reference

Dimensions Publication ID

13 September 2017

1008822394

0 references

Fatcat ID

release_y5iq7khyofazrdokegjd5hmyx4

0 references

1 reference